-+ 0.00%
-+ 0.00%
-+ 0.00%

MERCK ENTERS EXCLUSIVE GLOBAL LICENSE DEAL WITH SCIBRUNCH THERAPEUTICS FOR INVESTIGATIONAL ORAL KRAS G12D (ON) INHIBITOR SPR2015

Reuters·09/28/2026 11:07:45

Please log in to view news